Bionomics Limited (BNOX)
Bionomics Statistics
Share Statistics
Bionomics has 19.58M shares outstanding. The number of shares has increased by 83.07% in one year.
| Shares Outstanding | 19.58M |
| Shares Change (YoY) | 83.07% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 8.91% |
| Shares Floating | 80.69K |
| Failed to Deliver (FTD) Shares | 12.07K |
| FTD / Avg. Volume | 1.37% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is null. Bionomics's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0.06 |
| P/FCF Ratio | -0.05 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Bionomics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.45, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.45 |
| Quick Ratio | 3.45 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | -0.03 |
| Debt / FCF | -0.02 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.94B |
| Employee Count | 8 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -87.32M |
| Effective Tax Rate | 850.12% |
Stock Price Statistics
The stock price has increased by -97.8% in the last 52 weeks. The beta is -0.07, so Bionomics's price volatility has been lower than the market average.
| Beta | -0.07 |
| 52-Week Price Change | -97.8% |
| 50-Day Moving Average | 3.57 |
| 200-Day Moving Average | 7.11 |
| Relative Strength Index (RSI) | 47.66 |
| Average Volume (20 Days) | 881.89K |
Income Statement
| Revenue | n/a |
| Gross Profit | -434.45K |
| Operating Income | -17.89B |
| Net Income | -15.49B |
| EBITDA | -9.84M |
| EBIT | -10.27M |
| Earnings Per Share (EPS) | -1.02 |
Balance Sheet
The company has 12.61M in cash and 272.74K in debt, giving a net cash position of 12.34M.
| Cash & Cash Equivalents | 12.61M |
| Total Debt | 272.74K |
| Net Cash | 12.34M |
| Retained Earnings | -177.98M |
| Total Assets | 18.17M |
| Working Capital | 2.26M |
Cash Flow
In the last 12 months, operating cash flow was -14.68M and capital expenditures -4.44, giving a free cash flow of -14.68M.
| Operating Cash Flow | -14.68M |
| Capital Expenditures | -4.44 |
| Free Cash Flow | -14.68M |
| FCF Per Share | -1.47 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BNOX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for BNOX is $8, which is 3100% higher than the current price. The consensus rating is "Buy".
| Price Target | $8 |
| Price Target Difference | 3100% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Dec 24, 2024. It was a backward split with a ratio of 1:12.
| Last Split Date | Dec 24, 2024 |
| Split Type | backward |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | -16.24 |
| Piotroski F-Score | 5 |